More on COAG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:COAG)
Delayed: 48.97 +0.77 (1.60%)
Prev. Close $48.20  
Open$48.85 
52 Wk High$ 
52 Wk Low$ 
Day High$53.00 
Day Low$46.99 
P/E N/A  
EPS$ 
Volume270,835 


Aug 17, 2026 04:14 AM /C O R R E C T I O N -- The Galien Foundation/
Aug 14, 2026 05:07 PM Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: Novo Holdings A/S
Aug 14, 2026 09:02 AM Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: Avoro Capital Advisors LLC
Aug 13, 2026 09:00 AM The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and &q
Aug 12, 2026 10:28 AM Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: Capital International Investors
Aug 12, 2026 07:21 AM Hemab Therapeutics Holdings (COAG) PT Raised to $60 at H.C. Wainwright
Aug 11, 2026 04:01 PM Form 10-Q Hemab Therapeutics Holdi For: Jun 30
Aug 11, 2026 03:30 PM Hemab Therapeutics Holdings (COAG) PT Raised to $58 at Jefferies
Aug 11, 2026 07:11 AM Form 8-K Hemab Therapeutics Holdi For: Aug 11
Aug 11, 2026 07:00 AM Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
View All Articles

Entities mentioned with COAG

View All Entities